日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rapamycin combined with osimertinib alleviated non-small cell lung cancer by regulating the PARP, Akt/mTOR, and MAPK/ERK signaling pathways.

雷帕霉素联合奥希替尼通过调节 PARP、Akt/mTOR 和 MAPK/ERK 信号通路缓解非小细胞肺癌

Ma Qingrong, Chen Kai, Xiao Haiping

QTL mapping of yield-related traits in sesame

芝麻产量相关性状的QTL定位

Mei, Hongxian; Liu, Yanyang; Cui, Chengqi; Hu, Chengda; Xie, Fuxin; Zheng, Lei; Du, Zhenwei; Wu, Ke; Jiang, Xiaolin; Zheng, Yongzhan; Ma, Qingrong